APRI (Aprinoia Therapeutics) Change In Inventory: $0.00 Mil (TTM As of Dec. 2023)


What is Aprinoia Therapeutics Change In Inventory?

Aprinoia Therapeutics APRI Change In Inventory is $0.00 Mil as of Dec. 2023.

Aprinoia Therapeutics's change in inventory for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Aprinoia Therapeutics's inventory stayed the same from Jun. 2023 to Dec. 2023 .

Aprinoia Therapeutics's change in inventory for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means Aprinoia Therapeutics's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Aprinoia Therapeutics's Total Inventories for the quarter that ended in Dec. 2023 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Aprinoia Therapeutics's Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.


Aprinoia Therapeutics  (NAS:APRI) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Aprinoia Therapeutics's Days Inventory for the quarter that ended in is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Aprinoia Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Aprinoia Therapeutics's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aprinoia Therapeutics Change In Inventory Related Terms


Aprinoia Therapeutics Change In Inventory Historical Data

* Premium members only.

The historical data trend for Aprinoia Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aprinoia Therapeutics Change In Inventory Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Change In Inventory
0.00 0.00 0.00

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Change In Inventory 0.00 0.00 0.00 0.00 0.00

Aprinoia Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $0.00 Mil mean?
Aprinoia Therapeutics (APRI) has a Change In Inventory of $0.00 Mil as of Dec. 2023. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Aprinoia Therapeutics and its competitors.
Is Aprinoia Therapeutics' Change In Inventory too high?
Aprinoia Therapeutics' current Change In Inventory is $0.00 Mil.
How does Aprinoia Therapeutics' Change In Inventory compare to ?
Aprinoia Therapeutics' Change In Inventory of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Aprinoia Therapeutics and its competitors. Aprinoia Therapeutics's current Change In Inventory is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprinoia Therapeutics stock overvalued right now?
Aprinoia Therapeutics (APRI) has a current Change In Inventory of $0.00 Mil. The current Change In Inventory is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Aprinoia Therapeutics (APRI), the current Change In Inventory is $0.00 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aprinoia Therapeutics Business Description

Comparable Companies
Address 245 Main Street, 2nd Floor, Cambridge, MA, USA, 02142
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.